OverviewSuggest Edit

Icosavax is a biotechnology company that develops vaccines against infectious diseases. The startup creates virus-like particles (VLPs) and uses them in vaccines.

HQSeattle, US


Icosavax is headquartered in
Seattle, United States

Location Map

Latest Updates

Employees (est.) (Feb 2020)10(+12%)

Key People/Management at Icosavax

Adam Simpson

Adam Simpson

Chief Executive Officer
Douglas Holtzman

Douglas Holtzman

Chief Scientific Officer
Niranjan Kanesa-thasan

Niranjan Kanesa-thasan

Chief Medical Officer
Charles Richardson

Charles Richardson

Senior Vice President, Technical Operations
Jennifer Mitcham

Jennifer Mitcham

Senior Director, Global Program Management
Show more

Icosavax Office Locations

Icosavax has an office in Seattle
Seattle, US (HQ)
2815 Eastlake Ave E #300
Show all (1)

Icosavax Financials and Metrics

Summary Metrics

Founding Date


Icosavax total Funding

$51 m

Icosavax latest funding size

$51 m

Time since last funding

5 months ago

Icosavax investors

Icosavax's latest funding round in October 2019 was reported to be $51 m. In total, Icosavax has raised $51 m
Show all financial metrics

Icosavax Online and Social Media Presence

Embed Graph

Icosavax Frequently Asked Questions

  • When was Icosavax founded?

    Icosavax was founded in 2018.

  • Who are Icosavax key executives?

    Icosavax's key executives are Adam Simpson, Douglas Holtzman and Niranjan Kanesa-thasan.

  • How many employees does Icosavax have?

    Icosavax has 10 employees.

  • Who are Icosavax competitors?

    Competitors of Icosavax include U.S. Stem Cell, Endologix and Cannabis Sativa.

  • Where is Icosavax headquarters?

    Icosavax headquarters is located at 2815 Eastlake Ave E #300, Seattle.

  • Where are Icosavax offices?

    Icosavax has an office in Seattle.

  • How many offices does Icosavax have?

    Icosavax has 1 office.